Viral oncoproteins E1A and E7 and cellular LxCxE proteins repress SUMO modification of the retinoblastoma tumor suppressor
暂无分享,去创建一个
[1] Jie-Oh Lee,et al. Structure of the retinoblastoma tumour-suppressor pocket domain bound to a peptide from HPV E7 , 1998, Nature.
[2] S. Müller,et al. Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[3] L. Magnaghi-Jaulin,et al. Retinoblastoma protein represses transcription by recruiting a histone deacetylase , 1998, Nature.
[4] Tony Kouzarides,et al. Retinoblastoma protein recruits histone deacetylase to repress transcription , 1998, Nature.
[5] J. Harbour,et al. The Rb/E2F pathway: expanding roles and emerging paradigms. , 2000, Genes & development.
[6] B. Gallie,et al. The B-Domain Lysine Patch of pRB Is Required for Binding to Large T Antigen and Release of E2F by Phosphorylation , 2002, Molecular and Cellular Biology.
[7] Merlin Crossley,et al. Modification with SUMO , 2003, EMBO reports.
[8] F. Melchior,et al. SUMO--nonclassical ubiquitin. , 2000, Annual review of cell and developmental biology.
[9] M. Krstic-Demonacos,et al. Acetylation control of the retinoblastoma tumour-suppressor protein , 2001, Nature Cell Biology.
[10] W. Sellers,et al. Cells Degrade a Novel Inhibitor of Differentiation with E1A-Like Properties upon Exiting the Cell Cycle , 2000, Molecular and Cellular Biology.
[11] D. Riley,et al. Retinoblastoma protein directly interacts with and activates the transcription factor NF-IL6. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[12] F. Dick,et al. Three Regions of the pRB Pocket Domain Affect Its Inactivation by Human Papillomavirus E7 Proteins , 2002, Journal of Virology.
[13] S. Ao,et al. Identification and characterization of a novel human cDNA encoding a 21 kDa pRb-associated protein. , 2001, Gene.
[14] Sibylle Mittnacht,et al. Differential Phosphorylation of the Retinoblastoma Protein by G1/S Cyclin-dependent Kinases* , 1997, The Journal of Biological Chemistry.
[15] R. DePinho,et al. SUMO-1 Modification of Histone Deacetylase 1 (HDAC1) Modulates Its Biological Activities* , 2002, The Journal of Biological Chemistry.
[16] F. McCormick,et al. The RB and p53 pathways in cancer. , 2002, Cancer cell.
[17] J. Harbour,et al. Cdk Phosphorylation Triggers Sequential Intramolecular Interactions that Progressively Block Rb Functions as Cells Move through G1 , 1999, Cell.
[18] A. Sharrocks,et al. SUMO promotes HDAC-mediated transcriptional repression. , 2004, Molecular cell.
[19] Linda Smith,et al. Role of LXCXE motif-dependent interactions in the activity of the retinoblastoma protein , 2001, Oncogene.
[20] H. Hirai,et al. Cdk-mediated phosphorylation of pRB regulates HDAC binding in vitro. , 2004, Biochemical and biophysical research communications.
[21] M. Kagey,et al. The Polycomb Protein Pc2 Is a SUMO E3 , 2003, Cell.
[22] N. Perkins,et al. P300 transcriptional repression is mediated by SUMO modification. , 2003, Molecular cell.
[23] Erica S. Johnson,et al. An E3-like Factor that Promotes SUMO Conjugation to the Yeast Septins , 2001, Cell.
[24] Erica S. Johnson,et al. Protein modification by SUMO. , 2004, Annual review of biochemistry.
[25] A. Dejean,et al. Nuclear and unclear functions of SUMO , 2003, Nature Reviews Molecular Cell Biology.
[26] S. Reed,et al. Cyclin E-induced S phase without activation of the pRb/E2F pathway. , 1997, Genes & development.
[27] N. Dyson,et al. Retinoblastoma protein partners. , 2001, Advances in cancer research.
[28] S. Müller,et al. SUMO: a regulator of gene expression and genome integrity , 2004, Oncogene.
[29] Michael D. Schneider,et al. A Novel Rb- and p300-Binding Protein Inhibits Transactivation by MyoD , 2000, Molecular and Cellular Biology.
[30] C. Sherr,et al. Principles of Tumor Suppression , 2004, Cell.
[31] D. Dean,et al. Role of the LXCXE Binding Site in Rb Function , 2000, Molecular and Cellular Biology.
[32] A. Lassar,et al. pRb is required for MEF2-dependent gene expression as well as cell-cycle arrest during skeletal muscle differentiation , 1999, Current Biology.
[33] S. Müller,et al. PIAS/SUMO: new partners in transcriptional regulation , 2003, Cellular and Molecular Life Sciences CMLS.
[34] A. Dejean,et al. The Nucleoporin RanBP2 Has SUMO1 E3 Ligase Activity , 2002, Cell.
[35] E. Harlow,et al. The retinoblastoma tumour suppressor in development and cancer , 2002, Nature Reviews Cancer.
[36] G. G. Stokes. "J." , 1890, The New Yale Book of Quotations.
[37] A. Dejean,et al. c-Jun and p53 Activity Is Modulated by SUMO-1 Modification* , 2000, The Journal of Biological Chemistry.
[38] W. C. Forrester,et al. The retinoblastoma protein acts as a transcriptional coactivator required for osteogenic differentiation. , 2001, Molecular cell.
[39] S. Jentsch,et al. Ubiquitin and proteasomes: Sumo, ubiquitin's mysterious cousin , 2001, Nature Reviews Molecular Cell Biology.
[40] B. Spike,et al. New roles for the RB tumor suppressor protein. , 2004, Current opinion in genetics & development.
[41] Andrew J. Bannister,et al. Rb targets histone H3 methylation and HP1 to promoters , 2001, Nature.
[42] D. Nguyen,et al. Acetylation regulates the differentiation‐specific functions of the retinoblastoma protein , 2004, The EMBO journal.
[43] E. Miska,et al. The SUMO E3 ligase RanBP2 promotes modification of the HDAC4 deacetylase , 2002, The EMBO journal.
[44] Y. Chen,et al. Retinoblastoma protein positively regulates terminal adipocyte differentiation through direct interaction with C/EBPs. , 1996, Genes & development.
[45] D. Dean,et al. Rb Interacts with Histone Deacetylase to Repress Transcription , 1998, Cell.
[46] Yunje Cho,et al. Structural basis for the inactivation of retinoblastoma tumor suppressor by SV40 large T antigen , 2001, The EMBO journal.
[47] Jean Y. J. Wang,et al. Differential Regulation of Retinoblastoma Protein Function by Specific Cdk Phosphorylation Sites (*) , 1996, The Journal of Biological Chemistry.
[48] F. Dick,et al. Mutagenesis of the pRB Pocket Reveals that Cell Cycle Arrest Functions Are Separable from Binding to Viral Oncoproteins , 2000, Molecular and Cellular Biology.
[49] Jeong Ho Chang,et al. Structural basis for the recognition of the E2F transactivation domain by the retinoblastoma tumor suppressor. , 2002, Genes & development.
[50] M. Burghammer,et al. Crystal structure of the retinoblastoma tumor suppressor protein bound to E2F and the molecular basis of its regulation , 2003, Proceedings of the National Academy of Sciences of the United States of America.